We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

148 hedge funds and large institutions have $404M invested in Alaunos Therapeutics in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

41% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 34

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

14% more capital invested

Capital invested by funds: $354M → $404M (+$50.3M)

4% more funds holding

Funds holding: 142 → 148 (+6)

0.02% less ownership

Funds ownership: 0.34% → 0.32% (-0.02%)

49% less call options, than puts

Call options by funds: $5.06M | Put options by funds: $9.9M

Holders
148
Holders Change
+6
Holders Change %
+4.23%
% of All Funds
2.92%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
27
Increased
48
Reduced
34
Closed
20
Calls
$5.06M
Puts
$9.9M
Net Calls
-$4.84M
Net Calls Change
-$1.03M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.53M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$5.34M
3
Millennium Management
Millennium Management
New York
+$5.31M
4
DCM
Discovery Capital Management
Connecticut
+$2.32M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$5.36M
2
Morgan Stanley
Morgan Stanley
New York
-$2.19M
3
UBS Group
UBS Group
Switzerland
-$1.17M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$1.15M
5
MVP
Miller Value Partners
Florida
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Chevy Chase Trust
126
Chevy Chase Trust
Maryland
$24K +$22.7K +33 New
S
127
SignatureFD
Georgia
$17K – – –
GWM
128
Geneos Wealth Management
Colorado
$12K – – –
OSAM
129
O'Shaughnessy Asset Management
Connecticut
$12K +$11.7K +17 New
TWA
130
TCI Wealth Advisors
Arizona
$10K +$688 +1 +8%
1IA
131
1834 Investment Advisors
Wisconsin
$9K +$8.95K +13 New
EWM
132
EPG Wealth Management
Georgia
$9K +$8.95K +13 New
CWP
133
CFM Wealth Partners
Texas
$7K +$6.88K +10 New
APA
134
American Portfolios Advisors
New York
$6.14K – – –
Nisa Investment Advisors
135
Nisa Investment Advisors
Missouri
$5K – – –
WEC
136
Winslow Evans & Crocker
Massachusetts
$4K – – –
PA
137
PSI Advisors
Florida
$4K +$4.82K +7 New
JFA
138
JNBA Financial Advisors
Minnesota
$3K – – –
LWM
139
Lionsbridge Wealth Management
Florida
$3K +$3.44K +5 New
SFS
140
Sowell Financial Services
Arkansas
$2K -$688 -1 -25%
GWMIA
141
Global Wealth Management Investment Advisory
Florida
$2K – – –
US Bancorp
142
US Bancorp
Minnesota
$2K – – –
RWB
143
RMR Wealth Builders
New Jersey
$2K +$2.06K +3 New
Fidelity Investments
144
Fidelity Investments
Massachusetts
$1K -$2.06K -3 -75%
ASN
145
Advisory Services Network
Georgia
$1K – – –
FWM
146
Focused Wealth Management
New York
$1K – – –
WFMPM
147
Woodley Farra Manion Portfolio Management
Indiana
$1K +$688 +1 New
Federated Hermes
148
Federated Hermes
Pennsylvania
– -$1.07M -1,666 Closed
6CM
149
683 Capital Management
New York
– -$428K -667 Closed
TEE
150
Tibra Equities Europe
United Kingdom
– -$202K -315 Closed
3 4 5
6
7

TCRT Hedge Fund Activity: Q4 2019 in Review

148 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q4 2019, worth a combined $404M — up 14% from $354M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TCRT positions and 20 closed out — a net gain of 7 holders — while 48 added to existing stakes and 34 trimmed.

The largest buyer was Vanguard Group, adding an estimated $6.53M. The largest seller was State Street, cutting an estimated $5.36M.

  • 148 institutional investors held Alaunos Therapeutics (TCRT) as of Q4 2019, up from 142 in Q3 2019.
  • Funds reported $404M of Alaunos Therapeutics stock for Q4 2019, up 14% quarter-over-quarter.
  • 27 funds opened new Alaunos Therapeutics positions in Q4 2019 and 20 closed out, a net change of +7 holders.
  • The largest Alaunos Therapeutics buyer in Q4 2019 was Vanguard Group, an estimated $6.53M added.
  • The largest Alaunos Therapeutics seller in Q4 2019 was State Street, an estimated $5.36M sold.

Based on aggregated 13F filings for Q4 2019.